Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 3,226–3,250 of 7,816 matching trials · page 130 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Biological Sample Collection for Research and Biobanking NCT04270604 Biological sample collection Runs in: United States · 1 site |
NA other |
TERMINATED | 1,279 | New York Stem Cell Foundation Research Institute OTHER |
2024-08-02 |
|
Magnetic Imaging for Diagnostic of Amyotrophic Lateral Sclerosis NCT04868994 Whole Body MRI and ENMG Runs in: France · 1 site |
NA other |
UNKNOWN | 50 | University Hospital, Toulouse OTHER |
2024-08-02 |
|
Music-Based Interventions, Aging, Alzheimer's Disease NCT06152211 Choir; Group Music Listening Runs in: United States · 1 site |
NA other |
UNKNOWN | 66 | University of Southern California OTHER |
2024-08-02 |
|
Study on Multimodal Imaging and Molecular Imaging Techniques in Degenerative Dementia NCT06534658 Runs in: China · 8 sites |
NA other |
RECRUITING | 1,000 | Ruijin Hospital OTHER |
2024-08-02 |
|
Impact and Influence of the Use of Hypnosis Adapted to People With Severe Stage Neurocognitive Disorder (HAPNeSS) on the Professional Practices of EHPAD (Establishment for Dependent Elderly People) Caregivers With Elderly Residents NCT06535763 professional caregiver Runs in: France · 1 site |
NA other |
UNKNOWN | 36 | University Hospital, Bordeaux OTHER |
2024-08-02 |
|
Evaluation of the Use of a Novel Oral Health Screening Instrument by Caregivers in Nursing Homes NCT06536322 OHS-interRAI Runs in: Belgium · 1 site |
NA other |
UNKNOWN | 462 | KU Leuven OTHER |
2024-08-02 |
|
Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy NCT03657745 Combination of 40Hz light and cognitive therapy (ALZLIFE) Runs in: United States · 1 site |
NA other |
RECRUITING | 2,000 | Alzheimer's Light LLC INDUSTRY |
2024-08-01 |
|
Longitudinal Cognitive Assessment by BoCA NCT04114994 Boston Cognitive Assessment (BoCA) Runs in: United States · 1 site |
NA other |
RECRUITING | 10,000 | Alzheimer's Light LLC INDUSTRY |
2024-08-01 |
|
Natives Engaged in Alzheimers Research - 'Ike Kupuna NCT05534607 Ola Mau i ka Hula Runs in: United States · 3 sites |
NA other |
RECRUITING | 192 | University of Hawaii OTHER |
2024-08-01 |
|
The Effects of Music Listening on Anxiety and Agitation in People With Mild and Moderate Cognitive Impairment NCT05858541 Music Listening; Listening to Audiobooks Runs in: United States · 1 site |
NA other |
COMPLETED | 64 | University of Southern California OTHER |
2024-08-01 |
|
Bryostatin Treatment of Moderately Severe Alzheimer's Disease NCT04538066 Bryostatin 1; Placebo Runs in: United States · 19 sites |
PHASE2 other |
COMPLETED | 122 | Neurotrope Bioscience, Inc. INDUSTRY |
2024-07-31 |
|
A Study of Crenezumab Versus Placebo in Preclinical Presenilin1 (PSEN1) E280A Mutation Carriers to Evaluate Efficacy and Safety in the Treatment of Autosomal-Dominant Alzheimer's Disease (AD), Including a Placebo-Treated Non-Carrier Cohort NCT01998841 Crenezumab; Placebo Runs in: Colombia · 4 sites |
PHASE2 anti-amyloid-antibody |
COMPLETED | 252 | Genentech, Inc. INDUSTRY |
2024-07-30 |
|
HIV-HEART Aging Study NCT04330287 Runs in: Germany · 5 sites |
NA other |
UNKNOWN | 2,000 | University Hospital, Essen OTHER |
2024-07-30 |
|
Effect of the Administration of a Symbiotic (E. Faecium and Agave Inulin) on Mild Cognitive Impairment in Older Adults NCT05688618 Enteroccocus Facieum and Agave Inulin; Placebo Runs in: Mexico · 1 site |
NA other |
UNKNOWN | 48 | Anahuac University OTHER |
2024-07-30 |
|
Food Effect Study of BMS-984923 in Healthy Older Adult Volunteers NCT05817643 BMS-984923 Runs in: United States · 1 site |
PHASE1 other |
UNKNOWN | 12 | Allyx Therapeutics INDUSTRY |
2024-07-30 |
|
Impact of Resistance Training Volume on Cognitive Function and Physical Performance in Cognitively Impaired Individuals NCT06528951 Control Phase ( 6Weeks); 15% increase in resistance training volume... Runs in: Portugal · 1 site |
NA other |
UNKNOWN | 69 | University of Beira Interior OTHER |
2024-07-30 |
|
A Multidomain Approach to Preventing Dementia in African Americans: Cognitive Prescriptions NCT03864536 Cognitive Prescriptions Runs in: United States · 1 site |
NA other |
COMPLETED | 39 | University of Alabama at Birmingham OTHER |
2024-07-29 |
|
The Healthy Patterns Sleep Study NCT03682185 Attention-Control Condition; Timed Activity Intervention Runs in: United States · 1 site |
PHASE3 other |
COMPLETED | 421 | University of Pennsylvania OTHER |
2024-07-26 |
|
Electroacupuncture Treatment of Behavioral and Psycological Symptoms in Patients With Alzheimer's Disease NCT06523309 Electroacupuncture treatment Runs in: China · 7 sites |
NA other |
NOT_YET_RECRUITING | 1,000 | Guang'anmen Hospital of China Academy of Chinese Medical Sciences OTHER |
2024-07-26 |
|
Efficacy and Safety of S18986 in the Treatment of Mild Cognitive Impairment Patients NCT00202540 S18986 Runs in: France · 1 site |
PHASE2 other |
TERMINATED | 38 | Institut de Recherches Internationales Servier OTHER |
2024-07-25 |
|
Efficacy and Safety of 3 Doses of S47445 Versus Placebo in Patients With Alzheimer's Disease at Mild to Moderate Stages With Depressive Symptoms NCT02626572 S47445 5mg; S47445 15mg; S47445 50mg; Placebo Runs in: Brazil; Bulgaria; Chile; Czechia; Germany; Hungary; Japan... · 78 sites |
PHASE2 other |
COMPLETED | 500 | Institut de Recherches Internationales Servier OTHER |
2024-07-25 |
|
S-Equol in Alzheimer's Disease 2 Trial NCT03101085 S-equol and Placebo; Placebo and S-equol Runs in: United States · 2 sites |
PHASE1|PHASE2 other |
COMPLETED | 40 | Russell Swerdlow OTHER |
2024-07-25 |
|
Innovations in Dementia Empowerment and Action NCT03550131 Innovations in Dementia Empowerment and Action (IDEA); Reducing Dis... Runs in: United States · 1 site |
NA other |
COMPLETED | 322 | University of Washington OTHER |
2024-07-25 |
|
Health Behavior Change in Midlife Adults at Risk for Alzheimer's Disease NCT05599425 Enhanced Healthy Living Education; Basic Healthy Living Education Runs in: United States · 1 site |
NA other |
UNKNOWN | 40 | Rhode Island Hospital OTHER |
2024-07-25 |
|
Building Your Successful Nursing Career NCT06519643 career planning application |
NA other |
NOT_YET_RECRUITING | 120 | Chang Gung Memorial Hospital OTHER |
2024-07-25 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial